CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The Medtronic InSync III Marquis Cardiac Resynchronization Therapy Defibrillator (CRT-D)-System (implantable cardioverter-defibrillator with biventricular stimulation for cardiac resynchronization) is equipped with the "Conducted-Atrial Fibrillation (AF)-Response-Algorithm (CAFR)". This algorithm is designed to maximize biventricular stimulation and thus the amount of cardiac resynchronization when atrial fibrillation occurs. The goal of the study is the evaluation of the effect of the CAFR in CRT-patients suffering from atrial fibrillation by quantification of the increase of biventricular pacing during atrial fibrillation caused by CAFR as well as the influence of the CAFR on the ventricular heart rate.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Implant of a Medtronic InSync III Marquis (7279) or later system with Conducted AF-Response
Exclusion criteria
- Medical reasons that are adverse to participation in the study and compliance by the patient
- Patients who are enrolled in another study or plan to be enrolled into another study
- Pregnant patients or patients who are possibly pregnant due to an unreliable form of contraception
Trial design
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal